Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$63.64 - $125.14 $1,400 - $2,753
-22 Closed
0 $0
Q2 2024

Aug 02, 2024

BUY
$101.21 - $166.61 $2,226 - $3,665
22 New
22 $2,000
Q3 2023

Nov 07, 2023

BUY
$96.41 - $126.61 $6,748 - $8,862
70 Added 46.67%
220 $22,000
Q3 2021

Nov 10, 2021

BUY
$221.9 - $484.47 $33,285 - $72,670
150 New
150 $58,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track South State Corp Portfolio

Follow South State Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of South State Corp, based on Form 13F filings with the SEC.

News

Stay updated on South State Corp with notifications on news.